CompletedNCT03904186

Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

It focuses on depression and currently lists study information in the United States.

Depression, Anxiety, ...BehavioralFrom 18 Years to 79 Years

The study in practice

Understand this study

Listed age limits: 18 years to 79 years.

Listed locations: Boston, United States · Houston, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study start dateStarted: December 19, 2019

Recruitment status: Completed
Enrollment listed in the registry: 131
Sponsor: Massachusetts General Hospital
Sponsor type: Hospital / academic medical center
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 79 Years
Official registry ID: NCT03904186
Official title: Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

Completed

Boston · Houston

FAQ

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 79 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.